Skip to content
10-K

Annual Report

Q BIOMED INC.

0001410578-22-000230

← back to feed
Filed
Feb 28, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Feb 25, 2022 30.6M sh
Shares Diluted FY 2021 · Nov 30, 2020 22.16M sh
Operating Cash Flow FY 2021 · Nov 30, 2020 −$6.23M
Current Liabilities FY 2021 · Nov 30, 2020 $1.7M
Total Liabilities FY 2021 · Nov 30, 2020 $1.7M
Current Assets FY 2021 · Nov 30, 2020 $223.48K
Total Assets FY 2021 · Nov 30, 2020 $623.48K
Eps Diluted FY 2021 · Nov 30, 2020 −$0.65
Eps Basic FY 2021 · Nov 30, 2020 −$0.65
Rd Expense FY 2021 · Nov 30, 2020 $1.88M
Net Income FY 2021 · Nov 30, 2020 −$13.49M
Gross Profit FY 2021 · Nov 30, 2020 −$296.01K
Cost Of Revenue FY 2021 · Nov 30, 2020 $326.01K
Revenue FY 2021 · Nov 30, 2020 $30K
Stockholders Equity FY 2021 · Nov 30, 2019 −$5.05M